These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 27983491
1. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom. Baxter M, Morgan M. Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491 [Abstract] [Full Text] [Related]
2. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A. Clin Infect Dis; 2014 Sep 15; 59(6):851-7. PubMed ID: 24928291 [Abstract] [Full Text] [Related]
3. A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis. Nei T, Akutsu K, Shima A, Tsuboi I, Suzuki H, Yamamoto T, Tanaka K, Shinoyama A, Kojima Y, Washio Y, Okawa S, Sonobe K, Norose Y, Saito R. J Infect Chemother; 2012 Dec 15; 18(6):919-24. PubMed ID: 22327489 [Abstract] [Full Text] [Related]
4. Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases. Yoshizawa S, Matsumura T, Ikebe T, Ichibayashi R, Fukui Y, Satoh T, Tsubota T, Honda M, Ishii Y, Tateda K, Ato M. J Infect Chemother; 2019 May 15; 25(5):355-361. PubMed ID: 30744988 [Abstract] [Full Text] [Related]
5. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Norrby-Teglund A, Muller MP, Mcgeer A, Gan BS, Guru V, Bohnen J, Thulin P, Low DE. Scand J Infect Dis; 2005 May 15; 37(3):166-72. PubMed ID: 15849047 [Abstract] [Full Text] [Related]
6. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. Sriskandan S, Ferguson M, Elliot V, Faulkner L, Cohen J. J Antimicrob Chemother; 2006 Jul 15; 58(1):117-24. PubMed ID: 16670109 [Abstract] [Full Text] [Related]
7. Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited. Sendi P, El Hay MA, Brandt CM, Spellerberg B. Emerg Infect Dis; 2017 Jan 15; 23(1):150-152. PubMed ID: 27983484 [Abstract] [Full Text] [Related]
8. Toxic shock syndrome and streptococcal myositis: three case reports. Watkins R, Vyas H. Eur J Pediatr; 2002 Sep 15; 161(9):497-8. PubMed ID: 12200610 [Abstract] [Full Text] [Related]
9. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature. Tilanus AM, de Geus HR, Rijnders BJ, Dwarkasing RS, van der Hoven B, Bakker J. Int J Infect Dis; 2010 Sep 15; 14 Suppl 3():e208-12. PubMed ID: 19914115 [Abstract] [Full Text] [Related]
10. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R. Clin Infect Dis; 2014 Aug 01; 59(3):358-65. PubMed ID: 24785239 [Abstract] [Full Text] [Related]
11. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, Talbot J, Low DE. Clin Infect Dis; 1999 Apr 01; 28(4):800-7. PubMed ID: 10825042 [Abstract] [Full Text] [Related]
12. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome. Feigenberg T, Sela HY, Applbaum YH, Mankuta D. Isr Med Assoc J; 2008 Jun 01; 10(6):483-4. PubMed ID: 18669156 [No Abstract] [Full Text] [Related]
13. [Toxic shock-like syndrome caused by streptococci]. van Dissel JT, Kullberg BJ, van der Meer JW. Ned Tijdschr Geneeskd; 1999 Jul 10; 143(28):1452-5. PubMed ID: 10443259 [Abstract] [Full Text] [Related]
14. Streptococcal toxic shock syndrome - a life-threatening condition caused by various streptococcal species. Bartoš H, Fabianová L, Dlouhý P. Epidemiol Mikrobiol Imunol; 2018 Jul 10; 67(2):82-86. PubMed ID: 30126285 [Abstract] [Full Text] [Related]
15. Streptococcal toxic-shock syndrome due to Streptococcus dysgalactiae subspecies equisimilis in breast cancer-related lymphedema: a case report. Sumazaki M, Saito F, Ogata H, Yoshida M, Kubota Y, Magoshi S, Kaneko H. J Med Case Rep; 2017 Jul 14; 11(1):191. PubMed ID: 28705211 [Abstract] [Full Text] [Related]
16. Recurrent streptococcal toxic shock syndrome due to distinct episodes of Streptococcus dysgalactiae and Streptococcus agalactiae septic arthritis. Yun AE, Johnson LB. BMJ Case Rep; 2024 Aug 14; 17(8):. PubMed ID: 39142840 [Abstract] [Full Text] [Related]
17. An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C. Cone LA, Stone RA, Schlievert PM, Sneider RA, Rubin AM, Jesser K, Renker SW. Scand J Infect Dis; 2006 Aug 14; 38(11-12):960-3. PubMed ID: 17148061 [Abstract] [Full Text] [Related]
18. Infections due to group A streptococcus: new concepts and potential treatment strategies. Norrby SR, Norrby-Teglund A. Ann Acad Med Singap; 1997 Sep 14; 26(5):691-3. PubMed ID: 9494680 [Abstract] [Full Text] [Related]
19. Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection. Shah PJ, Vakil N, Kabakov A. Am J Health Syst Pharm; 2015 Jun 15; 72(12):1013-9. PubMed ID: 26025992 [Abstract] [Full Text] [Related]
20. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis. Parks T, Wilson C, Curtis N, Norrby-Teglund A, Sriskandan S. Clin Infect Dis; 2018 Oct 15; 67(9):1434-1436. PubMed ID: 29788397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]